Efficacy of Short-Term High-Dose Atorvastatin for Prevention of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography
dc.contributor.author | Özhan, Hakan | |
dc.contributor.author | Erden, İsmail | |
dc.contributor.author | Ordu, Serkan | |
dc.contributor.author | Aydın, Mesut | |
dc.contributor.author | Çağlar, Onur | |
dc.contributor.author | Başar, Cengiz | |
dc.contributor.author | Alemdar, Recai | |
dc.date.accessioned | 2020-05-01T09:12:08Z | |
dc.date.available | 2020-05-01T09:12:08Z | |
dc.date.issued | 2010 | |
dc.department | DÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description | WOS: 000281677000014 | en_US |
dc.description | PubMed: 20395226 | en_US |
dc.description.abstract | Contrast-induced nephropathy (CIN) is associated with increased morbidity, extended hospital stay, and higher costs. We compared an atorvastatin plus N-acetylcysteine (NAC) regimen with NAC alone in patients undergoing coronary angiography. A total of 130 patients (mean age 54 +/- 10; 77 men) undergoing coronary angiography were studied. Seven CIN cases occurred in the NAC group and 2 in the atorvastatin + NAC group; this difference was not significant. Baseline mean creatinine and estimated glomerular filtration rate (eGFR) were similar between the 2 groups, whereas after the procedure there was a significant creatinine decrease and eGFR increase in the atorvastatin + NAC group. Change in creatinine (baseline creatinine-creatinine after the procedure) was also significantly higher in patients taking statin plus NAC. Atorvastatin may be effective in protecting patients undergoing coronary angiography from CIN. | en_US |
dc.identifier.doi | 10.1177/0003319710364216 | en_US |
dc.identifier.endpage | 714 | en_US |
dc.identifier.issn | 0003-3197 | |
dc.identifier.issn | 1940-1574 | |
dc.identifier.issue | 7 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 711 | en_US |
dc.identifier.uri | https://doi.org/10.1177/0003319710364216 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12684/5886 | |
dc.identifier.volume | 61 | en_US |
dc.identifier.wos | WOS:000281677000014 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications Inc | en_US |
dc.relation.ispartof | Angiology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | contrast-induced nephropathy | en_US |
dc.subject | atorvastatin | en_US |
dc.subject | N-acetylcysteine | en_US |
dc.title | Efficacy of Short-Term High-Dose Atorvastatin for Prevention of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- 5886.pdf
- Boyut:
- 144.29 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text